Cargando…
Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors
AIM OF THE STUDY: The CD30L ligand is a membrane-associated glycoprotein expressed by activated CD4(+)Th cells, macrophages, dendritic cells, and B lymphocytes. It binds to the CD30 receptor carried on activated and helper Th cells, inducing the immune response and apoptosis. The aim of this retrosp...
Autores principales: | Chudecka-Głaz, Anita, Rzepka-Górska, Izabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687467/ https://www.ncbi.nlm.nih.gov/pubmed/23788939 http://dx.doi.org/10.5114/wo.2012.32485 |
Ejemplares similares
-
Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer
por: Chudecka-Głaz, Anita Monika, et al.
Publicado: (2014) -
Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
por: Chudecka-Głaz, Anita Monika, et al.
Publicado: (2015) -
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2014) -
Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014) -
Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
por: Pelser, Colleen, et al.
Publicado: (2010)